News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Beach
Vical Incorporated to Present at September Investor Conferences
August 29, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO, Aug. 29, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced scheduled presentations to provide an overview of the company's technologies, development programs, and outlook at four investor conferences in September:
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
February 13, 2026
·
6 min read
·
Heather McKenzie
Gene therapy
In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
February 11, 2026
·
4 min read
·
Heather McKenzie
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
·
4 min read
·
Heather McKenzie
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
·
6 min read
·
Heather McKenzie